Madrigal Pharmaceuticals clinical trials we track

Check company identity source

Phase 3 4 trials

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 1000 participants (planned). After: 810 participants (actual).

Primary completion date changed

Before: Mar 2026. After: Mar 2027.

Check registry source

· 3 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from baseline in hepatic fat fraction assessed by MRI-PDFF. After: Measure: Percent Change From Baseline To Week 12 In Hepatic Fat Fraction Assessed By Magnetic Resonance Imaging Proton Density Fat Fraction (MRI-PDFF).

Primary completion date changed

Before: Oct 2017. After: 25 Oct 2017.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Mean Percentage Change in LDL-C From Baseline To Week 12. After: Measure: Mean Percent Change in LDL-C From Baseline To Week 12.

Check registry source